EssilorLuxottica signs an agreement to acquire a majority stake in Heidelberg Engineering and continues to make moves in the med-tech space
17 July 2024 - 4:00PM
UK Regulatory
EssilorLuxottica signs an agreement to acquire a majority stake in
Heidelberg Engineering and continues to make moves in the med-tech
space
EssilorLuxottica signs an agreement to
acquire a majority stake in Heidelberg Engineering and continues to
make moves in the med-tech space
The transaction will create growth
opportunities for Heidelberg Engineering and confirms
EssilorLuxottica’s commitment to further elevating industry
standards and enhancing patients’ quality care
Paris, France and Heidelberg, Germany
(17 July 2024 – 8 am CEST) – EssilorLuxottica and
Heidelberg Engineering announced today they entered into an
agreement for the acquisition of an 80% stake in Heidelberg
Engineering, a Germany-based company specializing in diagnostic
solutions, digital surgical technologies and healthcare IT for
clinical ophthalmology. Drawing on EssilorLuxottica’s long-standing
expertise in the design and manufacture of advanced instruments and
vision care solutions for eyecare professionals, this agreement
represents a step forward in the Group’s strategy and its med-tech
journey.
Founded by Dr. Gerhard Zinser and Christoph
Schoess in 1990, Heidelberg Engineering brings extensive
technological and scientific expertise in optical coherence
tomography (OCT), real-time image processing and analytics,
large-scale data analysis and digital surgical navigation, to serve
medical professionals, scientists and researchers across a broad
range of ophthalmic areas.
With a presence in over 100 countries, for more
than three decades Heidelberg Engineering has been a reference in
early detection of sight-threatening conditions such as glaucoma
and age-related macular degeneration. As part of EssilorLuxottica,
Heidelberg Engineering will continue to serve the market under
their well-established brand, delivering the same solutions and
expertise their customers have come to expect and trust.
“Heidelberg Engineering, renowned for its
expertise in early detection and diagnosis, is a perfect fit for
EssilorLuxottica as it will bolster our presence in the med-tech
space. Heidelberg Engineering, with its commitment to research and
development, rooted in excellence, shares our core values. By
harnessing the full spectrum of our Group's capabilities in the
optical industry, from logistics to manufacturing to global
distribution, we are dedicated to fostering their long-term growth
while enhancing the doctor and patient experience,” commented
Francesco Milleri, Chairman and Chief Executive Officer, and Paul
du Saillant, Deputy Chief Executive Officer at
EssilorLuxottica.
"Innovation and quality have been key
drivers for Heidelberg Engineering ever since Gerhard Zinser and I
founded the company 35 years ago,” added Christoph Schoess,
co-founder and Managing Director of Heidelberg Engineering.
“Our mission has always been to develop products that provide
comprehensive, accurate, and clinically relevant information to aid
ophthalmologists in achieving better outcomes for their patients.
Our future goals include enhancing image quality through higher
resolution, expanding the applications of imaging technologies, and
integrating AI solutions into the growing HEYEX Healthcare IT
platform. We are delighted that EssilorLuxottica, a global leader
in eyecare, embraces our vision for creating a shared care system
spanning from research to home monitoring. Together, we are
strongly positioned to significantly advance patient care and
improve clinical outcomes.”
The transaction is expected to close in H2 2024
pending regulatory approvals and other customary closing
conditions.
- DOWNLOAD THE PRESS RELEASE
Essilorluxottica (BIT:1EL)
Historical Stock Chart
From Jun 2024 to Jul 2024
Essilorluxottica (BIT:1EL)
Historical Stock Chart
From Jul 2023 to Jul 2024
